EP2882751

DEUTERATED IBRUTINIB

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    30.7.2013
  • EP published:
    27.6.2018
  • EP application number:
    13745554.9
  • Max expiry date:
    29.7.2033
  • Title:
    DEUTERATED IBRUTINIB

Timeline

Today
30.7.2013EP application
27.6.2018EP Publication

Owner

  • Name:
    Concert Pharmaceuticals Inc.
  • Address:
    99 Hayden Avenue, Suite 500, 02421, Lexington, MA, US

Inventor

  • Name:
    TUNG, Roger, D.
  • Address:
    Lexington, MA, US
  • Name:
    MORGAN, Adam, J.
  • Address:
    Lexington, MA, US

Priority

  • Number:
    201261677307 P
  • Date:
    30.7.2012
  • Country:
    US

Classification

  • Categories:
    C07D 487/04, C07B 59/00, A61K 31/519

Upload documents